SELECTIVE INDUCTION OF APOPTOSIS IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA-CELLS BY AN INHIBITOR OF BCR-ABL TYROSINEKINASE, CGP-57148
S. Dan et al., SELECTIVE INDUCTION OF APOPTOSIS IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA-CELLS BY AN INHIBITOR OF BCR-ABL TYROSINEKINASE, CGP-57148, Cell death and differentiation, 5(8), 1998, pp. 710-715
The BCR-ABL tyrosine kinase has been implicated as the cause of Philad
elphia chromosome (Ph-1)-positive leukemias, We report herein that CGP
57148, a selective inhibitor of the ABL tyrosine kinase, caused apopt
osis specifically in bcr-abl-positive chronic myelogenous leukemia (CM
L) cells; K562 and KYO-1, Upon treatment with CGP 57148, CRKL, a speci
fic substrate for BCR-ABL that propagates signals via phosphatidylinos
itol-3' kinase (PI3K), was dephosphorylated, indicating inhibition of
BCR-ABL tyrosine kinase at the cellular level. Likewise, MAPK/ERK, a d
ownstream mediator of Ras, was also dephosphorylated. Caspase activati
on and cleavage of retinoblastoma protein (QRB) accompanied the develo
pment of CGP 57148-induced apoptosis. Inhibition of caspase suppressed
apoptosis and the cleavage of pRB, and in turn arrested cells in the
81 phase. These results indicate that CGP 57148 shows apoptogenic and
anti-proliferative effects on bcr-abl-positive cells by blocking BCR-A
BL-initiated signaling pathways.